Abstract
The study was designed to evaluate the management of acute myocardial infarction in the general medical wards of the National Hospital of Sri Lanka. All patients with acute myocardial infarction admitted from September 1996 to August 1997, were evaluated with regard to the time delay in admission and drug treatment. The facilities for monitoring and resuscitation were also assessed. A total of 259 patients were included in the study, 173 males and 86 females. The median time delay from the onset of the pain to admission at the out-patients department was 12 hours and that between out-patients department admission and ward admission was 20 minutes. The median delay in obtaining a 12-lead electrocardiogram when the patient was in the ward was 90 minutes. Review of the data showed that thrombolytic therapy, beta-blockers and angiotensin-converting enzyme inhibitors are underused. Complications were common. All the medical wards had adequate monitoring and resuscitation facilities. With adequate training of doctors and the availability of specialised cardiac nurses, thrombolytic therapy can be used effectively in medical wards. Keywords: myocardial infarction; Sri Lanka; thrombolysis
Full Text
The Full Text of this article is available as a PDF (58.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Constantine G. R., Thenabadu P. N. Time delay to thrombolytic therapy--a Sri Lankan perspective. Postgrad Med J. 1998 Jul;74(873):405–407. doi: 10.1136/pgmj.74.873.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
- Packer M. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol. 1996 Nov 1;28(5):1323–1327. doi: 10.1016/S0735-1097(96)00301-4. [DOI] [PubMed] [Google Scholar]
- Rogers W. J., Bowlby L. J., Chandra N. C., French W. J., Gore J. M., Lambrew C. T., Rubison R. M., Tiefenbrunn A. J., Weaver W. D. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994 Oct;90(4):2103–2114. doi: 10.1161/01.cir.90.4.2103. [DOI] [PubMed] [Google Scholar]
- Teo K. K., Yusuf S., Furberg C. D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993 Oct 6;270(13):1589–1595. [PubMed] [Google Scholar]